Fourier Intelligence Co., Ltd.
上海傅利叶智能科技有限公司
General-purpose humanoid robots and rehabilitation exoskeleton systems|Building 18, No. 258, Guoshoujing Road, Pudong New Area, Shanghai
Certifications
- ISO 13485 (Medical Devices Quality Management)
- CE Certification
- FDA Registration (Implied by global sales in 40+ countries)
- Class II Medical Device Production License
Main Products & Services
A global leader in AI robotics, transitioning from a pioneer in rehabilitation robotics to a developer of general-purpose humanoid robots.
Core Products
- GR-1 General-Purpose Humanoid Robot
- GR-2 Humanoid Robot (Research & Development Platform)
- GR-3 Care-Centric Humanoid Robot
- RehabHub™ Integrated Robotic Solution
- ArmMotus™ (Upper Limb Rehabilitation)
- LegMotus™ (Lower Limb Rehabilitation)
- ExoMotus™ (Exoskeleton Series)
- MetaMotus™ Galileo (Intelligent Biomechanical Evaluation)
Service Areas
- Healthcare and Rehabilitation
- Scientific Research and Education
- Commercial Services and Reception
- Manufacturing and Industrial Collaboration
- Dangerous Goods Protection
Features full-stack robotics technology, high-performance actuators, force control, multimodal interaction (speech, vision, touch), and hot-swappable battery systems.
Company Information
- Location
- Shanghai, China (Headquarters in Pudong New Area)
- Established
- 2015
- Registered Capital
- 4.049362 million RMB (Verified via Qichacha/Tianyancha)
- Business Scope
- Technical development and services in intelligent technology; R&D and sales of electrical/electronic equipment and computer software; production and sales of Class I and Class II medical devices; import and export of goods and technology.
- Production Capacity
- Operates production bases in Shanghai, Zhuhai, and Hefei; established a global supply chain for humanoid robot components.
- Financial Overview
- Raised over $234 million in total funding; Series D round raised $63 million (400 million RMB) led by SoftBank Vision Fund 2 and Prosperity7 Ventures (Saudi Aramco).
Innovation-driven, reliable, and accessible robotics technology.
Major Projects & Clients
Notable Projects
- RehabHub™ Ecosystem Development
- GRx Humanoid Series Global Launch
- Robot Training Center collaboration with China Construction Bank (Shanghai Branch)
Key Clients
- Over 2,000 hospitals and medical institutions globally
- ETH Zurich
- University of Melbourne
- University of Texas at Austin
- Tsinghua University
Industry Applications
- Medical Rehabilitation
- Elderly Care
- Academic Research
- Industrial Manufacturing
- Logistics
Team & R&D
Team size: Approximately 330 to 600 employees globally
R&D capabilities: High-intensity R&D focus with cumulative investment exceeding 500 million RMB; multiple global R&D centers.
Technical expertise: Full-stack robotics technology, humanoid biomechanics, embodied AI, and safe human-machine interaction.
Management
- Gu Jie (Alex Gu) - Founder and CEO
- Zen Koh - Co-founder and Global CEO
- Zhen-Hua Xu - CTO
Overseas Layout
Production Bases
- Shanghai, China: Main production and R&D headquarters: Building 12, No. 2388 Xiupu Road, Pudong New Area.
- Zhuhai, China: Production base: Building 3, Huafa Industrial Park, 129 Dingxing Road, Zhuhai National High-Tech Industrial Development Zone.
Sales Offices
- Singapore: International Headquarters: Marina One West Tower, 9 Straits View #05-07, Singapore 018937.
- Malaysia Kuala Lumpur: Regional Office: Level 8-2, Menara Pernas, Tower 7, Avenue 7, Bangsar South City, 59200 Kuala Lumpur.
- Australia Melbourne: R&D and Sales Hub: Level 2, 161 Collins Street, Melbourne, VIC 3000 (T&G Building); also Fourier Space at 453 Burwood Road, Hawthorn.
- USA Chicago: North American Office: 10 S. Riverside Plaza, Suite 875, Chicago, IL 60606.
- USA Arizona: US Headquarters/Office: Tempe, AZ (referenced in corporate job postings).
- United Kingdom London: European Sales Office: 184 Shepherds Bush Rd, London W6 7NL.
Investment Companies
- Fourier Intelligence International Pte. Ltd. — Singapore: Global management entity for international operations.
- Zhuhai RHK Healthcare — Zhuhai, China: Acquired in 2020 to expand rehab service ecosystem.
Global strategy: Operates a '1+3+X' strategy focusing on flagship scenarios (rehab) and partner scenarios (commercial, manufacturing, research) to build a global humanoid robot ecosystem.
Overseas revenue: Information not explicitly found, but serves over 40 countries and regions.